Brain tumor analysis is essential to the timely diagnosis and effective treatment of patients. Tumor analysis is challenging because of tumor morphology factors like size, location, texture, and heteromorphic appearance in medical images. In this regard, a novel two-phase deep learning-based framework is proposed to detect and categorize brain tumors in magnetic resonance images (MRIs). In the first phase, a novel deep-boosted features space and ensemble classifiers (DBFS-EC) scheme is proposed to effectively detect tumor MRI images from healthy individuals. The deep-boosted feature space is achieved through customized and well-performing deep convolutional neural networks (CNNs), and consequently, fed into the ensemble of machine learning (ML) classifiers. While in the second phase, a new hybrid features fusion-based brain-tumor classification approach is proposed, comprised of both static and dynamic features with an ML classifier to categorize different tumor types. The dynamic features are extracted from the proposed brain region-edge net (BRAIN-RENet) CNN, which is able to learn the heteromorphic and inconsistent behavior of various tumors. In contrast, the static features are extracted by using a histogram of gradients (HOG) feature descriptor. The effectiveness of the proposed two-phase brain tumor analysis framework is validated on two standard benchmark datasets, which were collected from Kaggle and Figshare and contain different types of tumors, including glioma, meningioma, pituitary, and normal images. Experimental results suggest that the proposed DBFS-EC detection scheme outperforms the standard and achieved accuracy (99.56%), precision (0.9991), recall (0.9899), F1-Score (0.9945), MCC (0.9892), and AUC-PR (0.9990). The classification scheme, based on the fusion of feature spaces of proposed BRAIN-RENet and HOG, outperform state-of-the-art methods significantly in terms of recall (0.9913), precision (0.9906), accuracy (99.20%), and F1-Score (0.9909) in the CE-MRI dataset.

Brain tumor classification is essential for clinical diagnosis and treatment planning. Deep learning models have shown great promise in this task, but they are often challenged by the complex and diverse nature of brain tumors. To address this challenge, we propose a novel deep residual and region-based convolutional neural network (CNN) architecture, called Res-BRNet, for brain tumor classification using magnetic resonance imaging (MRI) scans. Res-BRNet employs a systematic combination of regional and boundary-based operations within modified spatial and residual blocks. The spatial blocks extract homogeneity, heterogeneity, and boundary-related features of brain tumors, while the residual blocks significantly capture local and global texture variations. We evaluated the performance of Res-BRNet on a challenging dataset collected from Kaggle repositories, Br35H, and figshare, containing various tumor categories, including meningioma, glioma, pituitary, and healthy images. Res-BRNet outperformed standard CNN models, achieving excellent accuracy (98.22%), sensitivity (0.9811), F1-score (0.9841), and precision (0.9822). Our results suggest that Res-BRNet is a promising tool for brain tumor classification, with the potential to improve the accuracy and efficiency of clinical diagnosis and treatment planning.

The Coronavirus (COVID-19) outbreak in December 2019 has drastically affected humans worldwide, creating a health crisis that has infected millions of lives and devastated the global economy. COVID-19 is ongoing, with the emergence of many new strains. Deep learning (DL) techniques have proven helpful in efficiently analysing and delineating infectious regions in radiological images. This survey paper draws a taxonomy of deep learning techniques for detecting COVID-19 infection in radiographic imaging modalities Chest X-Ray, and Computer Tomography. DL techniques are broadly categorised into classification, segmentation, and multi-stage approaches for COVID-19 diagnosis at the image and region-level analysis. These techniques are further classified as pre-trained and custom-made Convolutional Neural Network architectures. Furthermore, a discussion is drawn on radiographic datasets, evaluation metrics, and commercial platforms provided for detection. In the end, a brief look is paid to emerging ideas, gaps in existing research, and challenges in developing diagnostic techniques. This survey provides insight into the promising areas of research in DL and is likely to guide the research community on the upcoming development of deep learning techniques for COVID-19. This will pave the way to accelerate the research in designing customised DL-based diagnostic tools for effectively dealing with new variants of COVID-19 and emerging challenges.

COVID-19 is a respiratory illness that has affected a large population worldwide and continues to have devastating consequences. It is imperative to detect COVID-19 at the earliest opportunity to limit the span of infection. In this work, we developed a new CNN architecture STM-RENet to interpret the radiographic patterns from X-ray images. The proposed STM-RENet is a block-based CNN that employs the idea of split–transform–merge in a new way. In this regard, we have proposed a new convolutional block STM that implements the region and edge-based operations separately, as well as jointly. The systematic use of region and edge implementations in combination with convolutional operations helps in exploring region homogeneity, intensity inhomogeneity, and boundary-defining features. The learning capacity of STM-RENet is further enhanced by developing a new CB-STM-RENet that exploits channel boosting and learns textural variations to effectively screen the X-ray images of COVID-19 infection. The idea of channel boosting is exploited by generating auxiliary channels from the two additional CNNs using Transfer Learning, which are then concatenated to the original channels of the proposed STM-RENet. A significant performance improvement is shown by the proposed CB-STM-RENet in comparison to the standard CNNs on three datasets, especially on the stringent CoV-NonCoV-15k dataset. The good detection rate (97%), accuracy (96.53%), and reasonable F-score (95%) of the proposed technique suggest that it can be adapted to detect COVID-19 infected patients.